Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity.
about
Recent Advances in Lentiviral Vaccines for HIV-1 InfectionPerspectives on reprograming cancer-associated dendritic cells for anti-tumor therapiesGene therapy on the movePros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesOptimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vectorA nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malariaDendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in miceImmunization delivered by lentiviral vectors for cancer and infectious diseases.Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells.Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAARTInduction of broadly neutralising HCV antibodies in mice by integration-deficient lentiviral vector-based pseudotyped particlesGeneration of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors.A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responsesSimian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines.Integration-deficient lentiviral vectors expressing codon-optimized R338L human FIX restore normal hemostasis in Hemophilia B mice.Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.Immunological therapy in urological malignancy: novel combination strategies.Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination.Assessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In Vivo.Retroviral and lentiviral vectors for the induction of immunological tolerance.Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammalsInduction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene.Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?Design and Potential of Non-Integrating Lentiviral Vectors.Recombinant Vaccines: Development, Production, and ApplicationIDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells
P2860
Q26742169-6BB897A2-276C-406E-90F1-82B827E0827BQ26830839-76D3E286-B612-4B43-B115-DEB301D187B4Q27007012-44770693-2B23-4DCF-81CF-5F724CF5D7BEQ27013679-E2DEF96D-DD6A-4E21-89E3-4FBE400458F4Q34166320-19F6C578-F415-40F3-AEB5-24A8E801B01EQ34469817-4177F286-5737-4808-9C46-F9677905367BQ34472125-EFA8B4C4-E043-4BCE-B68D-B8D9E2C280E3Q34539879-C69EB09B-A990-4ED2-8862-16E84883ED74Q34576498-57866758-F5AE-48D5-86F6-CB12DBEF23DAQ34647798-5BE8E31B-FDFB-429C-B01E-B382B6C6E467Q34693362-61DFAF4D-C96E-4E18-BCDF-436CEEEF3B00Q35878409-4CB7400D-AE5E-497C-B2C5-CB2A8A8270ADQ35990046-50396959-7175-44AE-AD4F-A4B7D9303E17Q36308990-4EADA54D-1D2E-4357-9063-0C460B46B1B8Q37620808-36DADC56-D73F-45B9-B131-09AD23431157Q37635491-DD0304D7-3A5E-41C2-A998-39B39CF6B23EQ37809109-CC836078-249A-4BE6-8CCC-2020030550F4Q37857291-99B77C8B-3F43-4FEE-92FC-2320E0943687Q38002844-3101819A-7F1E-458C-9743-3441487FD7CFQ39227747-32379B1A-0F42-47A9-BFAC-161268FCCC33Q41857863-96C20319-8B83-4955-BAC5-4888C14BF350Q41865429-FC9A2214-3A73-4A34-9DFF-06ABACD06CC9Q42250138-07DA2F2A-7C8D-47F7-95D1-B5B0E921AA06Q42910288-723EE4CB-31FA-4E13-A169-D244846DA2E7Q51851755-0A87EACB-109D-4692-89DD-6A926719E509Q56936206-11B80B2C-35E8-4C2D-81A4-8A27FD0752CFQ57117718-026FC53B-03C5-4C2E-B22D-B651675D15C1
P2860
Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vaccines delivered by integrat ...... ong antigen-specific immunity.
@ast
Vaccines delivered by integrat ...... ong antigen-specific immunity.
@en
Vaccines delivered by integrat ...... ong antigen-specific immunity.
@nl
type
label
Vaccines delivered by integrat ...... ong antigen-specific immunity.
@ast
Vaccines delivered by integrat ...... ong antigen-specific immunity.
@en
Vaccines delivered by integrat ...... ong antigen-specific immunity.
@nl
prefLabel
Vaccines delivered by integrat ...... ong antigen-specific immunity.
@ast
Vaccines delivered by integrat ...... ong antigen-specific immunity.
@en
Vaccines delivered by integrat ...... ong antigen-specific immunity.
@nl
P2093
P2860
P1433
P1476
Vaccines delivered by integrat ...... ong antigen-specific immunity.
@en
P2093
Biliang Hu
Bingbing Dai
P2860
P304
P356
10.1016/J.VACCINE.2010.08.012
P407
P577
2010-08-13T00:00:00Z